CompletedNot Applicable

CARE-HF Long Term Follow-up

United Kingdom309 participantsStarted 2006-09

Plain-language summary

The CARE-HF long-term follow-up trial evaluates the effects of cardiac resynchronization (CR) therapy on the mortality of patients from the CARE-HF program for an additional 4 year follow-up. Investigators are free to choose whatever available treatment they believe is in the patient's best interest.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients who have participated in the CARE-HF program and were reported to be alive in May 2005 * Patients who signed a patient data release consent form Exclusion Criteria: * Patients who have not participated in the CARE-HF program * Patients with exclusion criteria required by local legislation

What they're measuring

All Cause Mortality

Timeframe: 8-year

Trial details

NCT IDNCT00318357

SponsorMedtronic Cardiac Rhythm and Heart Failure

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2010-09

Results submitted2017-11-13

View on ClinicalTrials.gov More Heart Failure trials